What is Rolapitant: Uses, Dosage, Side Effects and More

Rolapitant is a prescription medication that helps prevent nausea and vomiting caused by chemotherapy treatments. It belongs to a class of drugs called NK1 receptor antagonists, which work by blocking specific signals in your brain that trigger these uncomfortable symptoms.

This medication is typically given as an injection into your vein (intravenously) before you receive chemotherapy. Healthcare providers use rolapitant as part of a comprehensive approach to help you feel more comfortable during cancer treatment.

What is Rolapitant Used For?

Rolapitant is specifically designed to prevent chemotherapy-induced nausea and vomiting (CINV). Your doctor will prescribe this medication when you're receiving certain types of cancer treatments that are known to cause these side effects.

The medication is particularly helpful for patients receiving highly emetogenic chemotherapy, which means treatments that have a high likelihood of causing nausea and vomiting. It's also used for moderately emetogenic chemotherapy regimens.

Rolapitant works best when used in combination with other anti-nausea medications like ondansetron and dexamethasone. This combination approach gives you the strongest protection against chemotherapy-related nausea and vomiting.

How Does Rolapitant Work?

Rolapitant blocks NK1 receptors in your brain that are responsible for triggering nausea and vomiting. When chemotherapy enters your system, it can activate these receptors, leading to those uncomfortable feelings.

By blocking these specific receptors, rolapitant prevents the nausea signals from reaching the parts of your brain that control vomiting. This makes it a targeted and effective medication for this particular problem.

The medication is considered moderately strong and provides long-lasting protection. Unlike some other anti-nausea drugs, rolapitant has a unique advantage because it stays active in your system for several days after a single dose.

How Should I Take Rolapitant?

Rolapitant is given as an intravenous injection by your healthcare team, usually 30 minutes to 2 hours before you receive chemotherapy. You won't need to take this medication at home or worry about timing it yourself.

The injection is typically given through an IV line in your arm or through a port if you have one. The process usually takes about 30 minutes, and you can sit comfortably during the infusion.

You don't need to eat or drink anything special before receiving rolapitant. However, your healthcare team may recommend eating a light meal beforehand if you're feeling up to it, as this can sometimes help with overall comfort during treatment.

How Long Should I Take Rolapitant For?

You'll typically receive rolapitant before each chemotherapy cycle that requires anti-nausea protection. The exact schedule depends on your specific cancer treatment plan and how often you receive chemotherapy.

Most patients receive rolapitant only on the days when they're getting chemotherapy treatments that are likely to cause nausea. Your oncologist will determine the appropriate schedule based on your treatment regimen.

The effects of a single rolapitant dose can last for several days, which means you're protected during the time when chemotherapy-induced nausea is most likely to occur. This extended protection is one of the medication's key benefits.

What Are the Side Effects of Rolapitant?

Like all medications, rolapitant can cause side effects, though many people tolerate it well. The most common side effects are generally mild and manageable.

Here are the more frequent side effects you might experience:

• Decreased appetite
• Dizziness or lightheadedness
• Hiccups
• Fatigue or tiredness
• Abdominal pain
• Urinary tract infections
• Stomatitis (mouth sores)

These side effects typically resolve on their own and don't require stopping the medication. Your healthcare team can help you manage any discomfort you experience.

Less common but more serious side effects can occur, though they're rare. These include severe allergic reactions, significant changes in heart rhythm, or severe dizziness that doesn't improve.

If you experience difficulty breathing, severe swelling, chest pain, or feel extremely unwell after receiving rolapitant, let your healthcare team know immediately. These symptoms are uncommon but require prompt attention.

Who Should Not Take Rolapitant?

Rolapitant isn't suitable for everyone, and your doctor will carefully review your medical history before prescribing it. People with certain conditions or those taking specific medications may need alternative treatments.

You should not receive rolapitant if you're allergic to it or any of its ingredients. Your healthcare team will ask about any previous reactions to anti-nausea medications before your first dose.

People taking certain medications may need special monitoring or dose adjustments. These include some blood thinners, seizure medications, and drugs that affect heart rhythm.

If you have severe liver problems, your doctor may choose a different anti-nausea medication or adjust your treatment plan. Rolapitant is processed by the liver, so severe liver disease can affect how your body handles the medication.

Pregnant and breastfeeding women require special consideration. While rolapitant hasn't been extensively studied in pregnancy, your oncologist will weigh the benefits against any potential risks if you're expecting or nursing.

Rolapitant Brand Names

Rolapitant is available under the brand name Varubi in the United States. This is the most commonly recognized name for the medication in clinical settings.

Your hospital or treatment center may refer to it by its generic name, rolapitant, or by the brand name Varubi. Both refer to the same medication with the same active ingredient.

When discussing your treatment with your healthcare team, either name is acceptable and they'll know exactly which medication you're referring to.

Rolapitant Alternatives

Several other medications can help prevent chemotherapy-induced nausea and vomiting if rolapitant isn't suitable for you. Your oncologist can recommend alternatives based on your specific needs and medical history.

Other NK1 receptor antagonists include aprepitant (Emend) and fosaprepitant (Emend for injection). These work similarly to rolapitant but have different dosing schedules and side effect profiles.

Your doctor might also consider other classes of anti-nausea medications like ondansetron (Zofran), granisetron (Kytril), or metoclopramide (Reglan). These medications work through different mechanisms but can be effective for preventing chemotherapy-related nausea.

The choice of alternative depends on factors like your other medications, medical conditions, and the specific type of chemotherapy you're receiving. Your healthcare team will work with you to find the most appropriate option.

Is Rolapitant Better Than Ondansetron?

Rolapitant and ondansetron work differently and are often used together rather than as alternatives to each other. They complement each other's effects by blocking different pathways that cause nausea and vomiting.

Ondansetron works by blocking serotonin receptors, while rolapitant blocks NK1 receptors. Using both medications together provides broader protection against chemotherapy-induced nausea than either drug alone.

In terms of effectiveness, studies show that combining rolapitant with ondansetron and dexamethasone provides better nausea control than using ondansetron alone. This combination approach is now standard care for many chemotherapy regimens.

The choice between using rolapitant alone versus in combination depends on your specific chemotherapy regimen and your individual risk factors for developing nausea and vomiting.